A study performed to investigate the response of tumor-specific CTLs to a therapeutic combination of interferon-γ-inducible protein-10 and melanoma TRP2-specific CD8+ CD28+ T cells embedded inside folate altered chitosan nanoparticles, showed an inhibition of melanoma cells in vivo. The gene discussed is CD8A; the disease is melanoma.